|
⚲
|
| Keyboard |
| Markus Goebel | |
|---|---|
| Firm | |
| Address | 4000 Shoreline Ct, Suite 400 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Macrolide Pharmaceuticals Inc | 021-307509 | Director | 12.0 M of 20.0 M |
||
| Effector Therapeutics Inc | 021-253725 | Director | 56.0 M of 56.0 M |
||
| E-Scape Bio Inc | 021-246718 | Director | 63.0 M of 63.0 M |
||
| RA Pharmaceuticals Inc | 021-244331 | Director | 29.2 M of 58.5 M |
||
| Merganser Biotech Inc | 021-234935 | Director | 13.1 M of 17.1 M |
||
| Effector Therapeutics Inc | 021-197112 | Director | 36.2 M of 57.0 M |
||
| Sorbent Therapeutics Inc | 021-182355 | Director | 18.1 M of 24.1 M |
||
| Ligocyte Pharmaceuticals Inc | 021-180453 | Director | 2.0 M of 22.1 M |
||
| Ligocyte Pharmaceuticals Inc | 021-161603 | Director | 5.5 M of 13.1 M |
||
| Sorbent Therapeutics Inc | 021-161402 | Director | 11.2 M of 36.0 M |
||
| Ligocyte Pharmaceuticals Inc | 021-140972 | Director | 6.6 M of 14.7 M |
||
| Trellis Bioscience Inc | 021-46810 | Director | 11.7 M of 13.5 M |
||